Diligence memo · auto-generated · as of July 2, 2026

Millennium Pharmacy Services, Inc.

Millennium Pharmacy Services, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Millennium Pharmacy Services, Inc. operates in Pharmaceuticals, based in OAK BROOK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Millennium Pharmacy Services, Inc. has raised $13M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $7.1M on 2010-11-19.

Most recent recorded round closed around 2010-11-19.

Valuation (modeled)modeled

Provath models Millennium Pharmacy Services, Inc. at approximately $219M (range $8.1M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.22× the median modeled value of Series A Pharmaceuticals companies in 2010–2012 (57 peers) — value vs value, same stage and era. Within the normal band (122% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 15.6 yr ago; this sector typically re-raises about every 13 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.3× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 59% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 70% of those peers.

Closest niche peers: Satori Pharmaceuticals Inc, Labrys Biologics, Inc., Telsar Pharma, Inc., Acetylon Pharmaceuticals, Inc., Seldar Pharma, Inc..

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.